ba0001pp503 | Paediatric bone disease | ECTS2013
Brunetti Giacomina
, Maria Felicia Faienza
, Piacente Laura
, Ventura Annamaria
, Oranger Angela
, Carbone Claudia
, Benedetto Adriana Di
, Colaianni Graziana
, Mori Giorgio
, Colucci Silvia
, Cavallo Luciano
, Grano Maria
Children with 21-hydroxylase deficiency (21-OHD) need chronic glucocorticoid (cGC) therapy to replace congenital deficit of cortisol synthesis, and this therapy is the most frequent and severe form of drug-induced osteoporosis. In the study we enrolled 18 patients (9 females) and 18 sex- and age-matched controls. We found in 21-OHD patients high serum and leukocyte levels of dickkopf-1 (DKK1), a secreted antagonist of the Wnt/β-catenin signaling pathway, known to be a key...